Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423)

Editorial Volume 4 Issue 2

Legalize Cannabis in the Indian Sub-Continent for Improving Economy and Health

Niranjan Aryal*

Lab Director at Certus Analytics, Murrieta California, USA

*Corresponding Author: Niranjan Aryal, Lab Director at Certus Analytics, Murrieta California, USA.

Received: December 27, 2019; Published: January 01, 2020

×

Abstract

  The cannabis has now been legalized for medicinal as well as recreational purposes in several countries in the west including some states in the United States. A large section of the society, farmers, distributors, patients, recreational consumers, and scientific researchers are already engaged in the cannabis industry. With more countries working on legalizing it medicinally or recreationally or both ways, cannabis is going to be one of the major determinants for the economy in the coming years.

  Despite very long human-cannabis relationship, the Indian sub-continent seems to be lagging on the utilization of this valuable plant. Though the plant's medicinal values were mentioned in the Vedas and several other Indian books some thousand years ago, the subcontinent could not effectively translate and transcribe the ancient knowledge. The present bureaucracy in the subcontinent seems to be reluctant to even discussing the plant’s importance in the economy or any other aspects. Several universities in the west have already started the research programs and have reported several conclusive results showing the medicinal importance of chemical compounds produced by the cannabis plant. The Indian subcontinent, in contrast does not even bother to try interpreting the knowledge that is widely practiced in different cultures and was clearly mentioned in ancient books.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US